References
Done AK (1960) Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion. Pediatrics 26:800–807
Dugandzic RM, Tierney MG, Dickinson GE, Dolan MC, McKnight DR (1989) Evaluation of the validity of the Done nomogram in the management of acute salicylate intoxication. Ann Emerg Med 18(11):1186–1190
Alvan G, Bergman U, Gustafsson LL (1981) High unbound fraction of salicylate in plasma during intoxication. Br J Clin Pharmacol 11:625
Hill JB (1971) Experimental salicylate poisoning: observations on the effects of altering blood pH on tissue and plasma salicylate concentrations. Pediatrics 47:658–665
Stolbach AI, Hoffman RS, Nelson LS (2008) Mechanical ventilation was associated with acidemia in a case series of salicylate-poisoned patients. Acad Emerg Med 15(9):866–869
Adelman HM, Wallach PM, Flannery MT (1991) Inability to interpret toxic salicylate levels in patients taking aspirin and diflunisal. J Rheumatol 18(4):522–523
Jacob J, Lavonas EJ (2011) Falsely normal anion gap in severe salicylate poisoning caused by laboratory interference. Ann Emerg Med 58(3):280–281
Bradberry SM, Vale JA (1995) Multiple-dose activated charcoal: a review of relevant clinical studies. J Toxicol Clin Toxicol 33:407
Juurlink DN, McGuigan MA (2000) Gastrointestinal decontamination for enteric-coated aspirin overdose: what you do depends on who you ask. J Toxicol Clin Toxicol 38:465
Proudfoot AT, Krenzelok EP, Vale JA (2004) Position paper on urinary alkalinization. J Toxicol Clin Toxicol 42:1
Fertel BS, Nelson LS, Goldfarb DS (2009) The underutilization of hemodialysis in patients with salicylate poisoning. Kidney Int 75(12):1349–1353
American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists (1999) Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 37:731
American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists (2005) Position paper: single-dose activated charcoal. Clin Toxicol 43:61
Author information
Authors and Affiliations
Consortia
Additional information
Disclaimer
While individual practitioners may differ, this is the position of the college at the time written, after a review of the issue and pertinent literature. This document identifies critical management priorities for the salicylate-poisoned patient. It is not intended as a clinical guideline or substitute for clinical consultation with a medical toxicologist and a nephrologist.
Rights and permissions
About this article
Cite this article
American College of Medical Toxicology. Guidance Document: Management Priorities in Salicylate Toxicity. J. Med. Toxicol. 11, 149–152 (2015). https://doi.org/10.1007/s13181-013-0362-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-013-0362-3